WAVE Life Sciences
Manufacturing · Massachusetts, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
733 Concord Ave, Cambridge, Massachusett...Phone Number
(617) 949-2900Website
www.wavelifesciences.comRevenue
$71.8 MillionStock Symbol
WVEIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About WAVE Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company's proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future.Explore more
WAVE Life Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is WAVE Life Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
WAVE Life Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when WAVE Life Sciences launches new products
Check out if WAVE Life Sciences is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at WAVE Life Sciences
Check if WAVE Life Sciences has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on WAVE Life Sciences recently announced quarterly report
Click to see if WAVE Life Sciences had a recent Job posting/layoffs
Funding: Get notified immidiatlly once WAVE Life Sciences has new funding data
Recommended Actions
Reach out to Masked Content who joined WAVE Life Sciences as Masked Content
Find 2 more new buyers
Compare Similar Companies to WAVE Life Sciences
Compare insights from companies similar to WAVE Life Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
WAVE Life Sciences
$71.8M
201-500
Public
$451.3M
2012
LR
Linda RockettSenior Vice President, General Counsel
Company Profile Activity
Activity Insights
WAVE Life Sciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
WAVE Life Sciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about WAVE Life Sciences.
WAVE Life Sciences financials insights
Gather financial insights about WAVE Life Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Multiple Rounds
$196M
2017
Stock Offering
$93.5M
2019
Stock Offering
$161.8M
WAVE Life Sciences Tech Stack
A closer look at the technologies used by WAVE Life Sciences
See more technologies
Most Recent Scoops
Open Position
Project
WAVE Life Sciences has announced that it expects regulatory feedback this summer on next steps toward accelerated approval for its AATD program, with the established regulatory benchmark set at total AAT levels greater than 11 micromolar.
Pharmaceuticals
Project
WAVE Life Sciences has announced plans to initiate a combination study evaluating its INHBE program alongside incretins, including tirzepatide at starting doses such as 5 mg, with the goal of maximizing fat loss and lean mass preservation while improving tolerability and adherence without escalating incretin doses.
Medical Research, Pharmaceuticals
Project
WAVE Life Sciences has reported key biomarker data from its AATD program, including a substantial reduction in Z protein, 64% M wild-type protein in circulation in the MZ patient population, total AAT levels meeting or exceeding the MZ phenotype threshold, and a dynamic acute phase response producing over 20 micromolar of protein during acute phase events sustained for months before returning to baseline.
Medical Research, Pharmaceuticals
Project
Medical Research, Pharmaceuticals
WAVE Life Sciences News & Media
Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT™ Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases
In Phase 1 portion of trial, WVE-007 improved body composition by inducing fat loss, including harmful visceral fat, while maintaining muscle; data continue to support once or twice-yearly dosingIs Wave Life Sciences Ltd. (WVE) A Good Stock To Buy Now?
Is WVE a good stock to buy? We came across a bullish thesis on Wave Life Sciences Ltd. on Biotech Distilled’s Substack. In this article, we will summarize the bulls’ thesis on WVE. Wave Life Sciences Ltd.’s share was trading at $5.70 as of June 8th. Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and […]Wave Life Sciences Ltd. (WVE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Wave Life Sciences Ltd. (WVE) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 8:00 AM EDTCompany ParticipantsPaul Bolno -...Wave Life Sciences to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass., June 01, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that members of Wave’s management team are scheduled to participate in two upcoming investor conferences in June.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding WAVE Life Sciences
Sign Up For FreeTo access detailed company insights
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company's proprietary discovery and drug development platform that enables t... Read More
